The SWEET Team
The SWEET programme is led by academics from Newcastle University and Oxford Brookes University who are experts in cancer survivorship research and adherence to hormone therapy.
The wider research team involves several other Universities and NHS Hospital Trusts and includes patient representatives, breast cancer specialists (surgeons, oncologists, nurses, dietician), a GP, a pharmacist, psychologists and researchers with expertise in breast cancer studies, running trials, statistics and health economics.
Co-Lead Investigators
Co-Lead Investigator
Professor of Supportive Cancer Care
Oxford Brookes University
The Core Team
Patient Advisory Group
Our patient advisory group (The PAG) is made up of 11 women who have been prescribed hormone therapy for breast cancer. They have been, and continue to be, actively involved throughout the research programme, including developing design and content of the support package, testing usability, advising on patient-facing materials, reviewing questionnaires, reviewing emerging findings, and contributing to dissemination.
Patient Advisory Group Chairs
Jan Rose
PAG co-chair
Sharing my experiences with PAG members and researchers, to create the HT&Me website, is important. I hope it will benefit future patients taking hormone therapy.
Lesley Turner
PAG co-chair
I am a breast cancer patient. I strongly believe that women deserve better tools to support them navigate their endocrine therapy and improve their quality of life.
Patient Advisory Group Members
Akos Adu
As a breast cancer survivor, I know how important it is to have comprehensive help available easily. It is absolutely useful in supporting our health journey.
Jan Backhouse
Having run breast support groups, I have met many ladies unable to get appropriate hormone therapy support. A website like HT&Me is an oasis in the desert, and will be valued!
Sue Bailey
I am a breast cancer patient. By being part of the SWEET PAG I hope we have improved the support available and health outcomes for other women taking hormone therapy.
Birgit Cloos
I have had breast cancer and I am a healthcare professional. I would like to support women who are on endocrine therapy and contribute with my experience and knowledge.
Jane Coogan
Having had breast cancer, I know the importance of taking hormone therapy. I hope my participation will help patients make informed choices.
Rosemary Dooley
I have had breast cancer and struggled with severe endocrine therapy side effects. I feel my experience has enabled me to help others through contributing to this research.
Helen Howitt
After 30 years in Clinical Research I wanted to give back after my own diagnosis, having learnt how critical supporting patients with their medication is.
Adrienne Morgan
I might not have retired if this resource had been available after my diagnosis in 2005 - insomnia, hot flushes, sexual dysfunction! I am so proud to be part of the team.
Plus one more member who chose not to be included on the SWEET public website.
Community of Interest
Our Community of Interest is made up of a group of 28 women who have previously had breast cancer and have been prescribed hormone therapy. They advise us on an ad hoc basis, via email, on a range of topics based on their real-life experience which have helped to inform the HT&Me support package.
The wider research team
SWEET Co-applicants
Dr Caitriona Cahir
Co-applicant
Lecturer, Data Science Centre, School of Population Health, Royal College of Surgeons in Ireland
Mr Peter Donnelly
Co-applicant
Honorary Research Consultant and retired Breast Surgeon to Torbay and South Devon NHS Foundation Trust
Professor Janet Dunn
Co-applicant
Professor of Clinical Trials and Head of cancer trials at Warwick Clinical Trials Unit at Warwick Medical School
Professor Debbie Fenlon
Co-applicant
Professor of Nursing, Swansea University
Professor Rob Horne
Co-applicant
Professor of Behavioural Medicine, University College London
Dr Lyndsey Hughes
Co-applicant
Senior Lecturer in Health Psychology, King’s College London
Dr Brian Nicholson
Co-applicant
NIHR Academic Clinical Lecturer Nuffield Department of Primary Care Health Sciences, University of Oxford
Mrs Jan Rose
Co-applicant
NCRI- National Cancer Research Institute
Professor Adam Todd
Co-applicant
Reader in Pharmaceutical Public Health, Newcastle University
Mrs Lesley Turner
Co-applicant
Independent Cancer Patients’ Voice
Professor Andrew Wardley
Co-applicant
CEO & Medical Director of Outreach Research & Innovation Group. Co-Founder Manchester Breast Centre. NHS Consortium Technical Advisor.
Dr Jane Wolstenholme
Co-applicant
Associate Professor of Health Economics, University of Oxford
SWEET Collaborators
Mr Henry Cain
Collaborator
Consultant Oncoplastic Breast Surgeon, Newcastle Upon Tyne Hospital NHS Foundation Trust
Helen Dakin
Collaborator
Health Economist, University of Oxford
Dr Victoria Harmer
Collaborator
Consultant Breast Nurse, Imperial College Healthcare NHS Trust
Dr Louise Hiller
Collaborator
Associate Professor in Medical Statistics, University of Warwick
Dr Alex King
Collaborator
Consultant Clinical Psychologist & Lead for Psycho-Oncology, Imperial College Healthcare NHS Trust
Sally Kum
Collaborator
Associate Director of Nursing and Health Information, Breast Cancer Now
Dr Nicky Levitt
Collaborator
Consultant in Medical Oncology, Oxford University Hospitals NHS Foundation Trust
Professor Colin McCowan
Collaborator
Professor in Health Data Science, University of St Andrews
Dr Zoe Moon
Collaborator
Senior Research Fellow, University College London
Dr Farah Rehman
Collaborator
Consultant Medical Oncologist and Honorary Clinical Senior Lecturer, Imperial College Healthcare NHS Trust
Professor Sam Smith
Collaborator
Professor, University of Leeds
Mr Simon Vincent
Collaborator
Director of Research, Support and Influencing at Breast Cancer Now, Breast Cancer Now
Partners
We are working with the following organisations as partners
